source
- Boehringer's obesity drug shows up to 9.8% weight loss in diabetes patients but lags behind competitorsBoehringer Ingelheim presented data at the European Association for the Study of Diabetes (EASD) meeting in Milan, showing its lead obesity candidate achieved up to 9.8% weight reduction in a late-…
- Study finds AI may be driving up healthcare costsA recent analysis by the Blue Cross Blue Shield Association challenges the common belief that artificial intelligence will lower healthcare spending. The report argues that, instead of delivering…